The preclinical and clinical activity of aviscumine: a potential anticancer drug.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Cancer

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2011.02.022PMID 21482461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas

  2009cited by this paper
• Twelve immunotherapy drugs that could cure cancers.

  2008cited by this paper
• alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.

  2008cited by this paper
• Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: a study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001).

  2008cited by this paper
• Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells.

  2006cited by this paper
• Increased α2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells

  2006cited by this paper
• Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lung.

  2005cited by this paper
• Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours.

  2005cited by this paper
• Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group.

  2004cited by this paper
• Cytotoxicity of the novel anti-cancer drug rViscumin depends on HER-2 levels in SKOV-3 cells.

  2004cited by this paper
• Sialyltransferase mRNA abundances in B cells are strictly controlled, correlated with cognate lectin binding, and differentially responsive to immune signaling in vitro.

  2004cited by this paper
• Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues.

  2004cited by this paper
• Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation

  2003cited by this paper
• Mistletoe in cancer - a systematic review on controlled clinical trials.

  2003cited by this paper
• CD75s is a marker of murine CD8(+) suppressor T cells.

  2003cited by this paper
• Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells.

  2002cited by this paper
• Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expression.

  2002cited by this paper
• Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides.

  2002cited by this paper
• Differential expression of beta-galactoside alpha2,6 sialyltransferase and sialoglycans in normal and cirrhotic liver and hepatocellular carcinoma.

  2002cited by this paper
• Cell surface α2,6-sialylation affects adhesion of breast carcinoma cells

  2002cited by this paper
• Differential Expression of β-Galactoside α2,6 Sialyltransferase and Sialoglycans in Normal and Cirrhotic Liver and Hepatocellular Carcinoma

  2002cited by this paper
• Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases

  2002cited by this paper
• rViscumin, a novel anticancer agent — preclinical and clinical development status

  2001cited by this paper
• Combined cytotoxic action of Viscum album agglutinin-1 and anticancer agents against human A549 lung cancer cells.

  2001cited by this paper
• Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model

  2001cited by this paper
• Clinicopathologic evaluation of CDw75 antigen expression in patients with gastric carcinoma

  2001cited by this paper
• Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.

  2001cited by this paper
• Assessing the cancerostatic potency of rViscumin towards human tumor xenografts and cell lines in vitro

  2001cited by this paper
• Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice.

  2000cited by this paper
• Activation of human neutrophils by the plant lectin Viscum album agglutinin‐I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis

  2000cited by this paper
• β‐galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with sambucus nigra agglutinin

  2000cited by this paper
• Characterization of recombinant and plant-derived mistletoe lectin and their B-chains.

  1999cited by this paper
• Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.

  1999cited by this paper
• Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.

  1999cited by this paper
• Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis.

  1999cited by this paper
• How useful are unconventional cancer treatments?

  1999cited by this paper
• Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.

  1999cited by this paper
• Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain.

  1999cited by this paper
• Complementary Medicine in Cancer Patients: Demand, Patient’ Attitudes and Psychological Beliefs

  1998cited by this paper
• Effect of a Recombinant Lectin, Viscum album Agglutinin on the Secretion of Interleukin-12 in Cultured Human Peripheral Blood Mononuclear Cells and on NK-Cell-Mediated Cytotoxicity of Rat Splenocytes in vitro and in vivo

  1998cited by this paper
• Apoptosis and cytokine release are biological responses mediated by recombinant mistletoe lectin in vitro

  1997cited by this paper
• Mistletoe treatment for cancer review of controlled trials in humans.

  1994cited by this paper
• Purification of immune complexes clearance enhancing polysaccharide from the leaves of panax ginseng, and its biological activities.

  1994cited by this paper
• Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients

  1992cited by this paper
• Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.

  1989cited by this paper
• Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes.

  1989cited by this paper
• The site of action of the A‐chain of mistletoe lectin I on eukaryotic ribosomes The RNA N‐glycosidase activity of the protein

  1988cited by this paper

• Vatairea Genus as a Potential Therapeutic Agent—A Comprehensive Review of Ethnobotanical, Phytochemical, and Pharmacological Properties

  2025cites this paper
• Novel Lectins from Bauhinia with Differential N-Glycan Binding Profiles

  2025cites this paper
• The Antioxidant Activity of Mistletoes (Viscum album and Other Species)

  2023cites this paper
• The Anti-Inflammatory Activity of Viscum album

  2023cites this paper
• Mistletoe lectin inhibits growth of Myc‐amplified small‐cell lung cancer

  2022cites this paper
• Plant lectin: A promising future anti-tumor drug.

  2022cites this paper
• Viscum album L. (Santalaceae)

  2020cites this paper
• Dietary Lectins: Gastrointestinal and Immune Effects

  2020cites this paper
• Jarosite wastes reduction through blast furnace sludges for cast iron production

  2019cites this paper
• Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression

  2019cites this paper
• Plant Molecular Farming – Integration and Exploitation of Side Streams to Achieve Sustainable Biomanufacturing

  2019cites this paper
• Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term Mistletoe extract treatment

  2019cites this paper
• Comparison of microbial and transient expression (tobacco plants and plant‐cell packs) for the production and purification of the anticancer mistletoe lectin viscumin

  2019influential citation
• Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice

  2019cites this paper
• Phytotherapeutics in cancer invasion and metastasis

  2018cites this paper
• Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice

  2018cites this paper
• Plants as sources of natural and recombinant anti-cancer agents.

  2018cites this paper
• Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy

  2017cites this paper
• Simultaneous identification and quantification of the common compounds of Viscum coloratum and its corresponding host plants by ultra-high performance liquid chromatography with quadrupole time-of-flight tandem mass spectrometry and triple quadrupole mass spectrometry.

  2017cites this paper
• Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.

  2017cites this paper
• How Plants Can Contribute to the Supply of Anticancer Compounds

  2017cites this paper
• The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis

  2017cites this paper
• Viscumins functionally modulate cell motility-associated gene expression.

  2017cites this paper
• Structural analysis of Centrolobium tomentosum seed lectin with inflammatory activity.

  2016cites this paper
• European Viscum album: a potent phytotherapeutic agent with multifarious phytochemicals, pharmacological properties and clinical evidence

  2016cites this paper
• Cancer therapy with phytochemicals: evidence from clinical studies

  2015cites this paper
• Plant Lectins in Therapeutic and Diagnostic Cancer Research

  2015cites this paper
• A novel vasorelaxant lectin purified from seeds of Clathrotropis nitida: partial characterization and immobilization in chitosan beads.

  2015cites this paper
• Lectins with Potential for Anti-Cancer Therapy

  2015influential citation
• Development of a sensitive ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of nine active compounds in rat plasma and its application to a pharmacokinetic study after administration of Viscum coloratum extracts.

  2015cites this paper
• Marine lectins and their medicinal applications

  2015cites this paper
• REVIEW ARTICLE: CANCER THERAPY WITH PHYTOCHEMICALS: EVIDENCE FROM CLINICAL STUDIES

  2015cites this paper
• BUL: a novel lectin from Bauhinia ungulataL. seeds with fungistatic and antiproliferative activities

  2014cites this paper
• Purification and Partial Characterization of a New Mannose/Glucose-Specific Lectin from Centrolobium tomentosum Guill. ex Benth Seeds Exhibiting Low Toxicity on Artemia sp.

  2014cites this paper
• Ribosome‐inactivating Proteins in Cancer Treatment

  2014cites this paper
• A New Flavonoid Glycoside and Four Other Chemical Constituents from Viscum coloratum and Their Antioxidant Activity

  2014cites this paper
• Isolation and characterization of a lectin from Japanese mottled beans.

  2014cites this paper
• BUL: A novel lectin from Bauhinia ungulata L. seeds with fungistatic and antiproliferative activities

  2014cites this paper
• Recombinant production of plant lectins in microbial systems for biomedical application – the frutalin case study

  2014cites this paper
• The Relationship Between Lectin Compounds and Immunomodulatory Activities of Protein Extracted From Plants

  2013cites this paper
• The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties

  2013cites this paper
• Ribosome Inactivating Proteins from Plants: Biological Properties and their Use in Experimental Therapy

  2013cites this paper
• Emerging roles of mistletoes in malignancy management

  2013cites this paper
• The use of mistletoe extracts in cancer patients

  2013cites this paper
• Purification and partial characterization of a new mannose/glucose‐specific lectin from Dialium guineense Willd seeds that exhibits toxic effect

  2013cites this paper
• Recombinant lectins: an array of tailor-made glycan-interaction biosynthetic tools

  2013cites this paper
• Neutrophil activation induced by plant lectins: modulation of inflammatory processes.

  2012cites this paper
• Purification and characterization of riproximin from Ximenia americana fruit kernels.

  2012cites this paper
• Purification and primary structure determination of a galactose-specific lectin from Vatairea guianensis Aublet seeds that exhibits vasorelaxant effect

  2012cites this paper
• Mistelpräparate zur Behandlung urologischer Tumoren

  2012cites this paper
• A Lectin with Anti-proliferative, Mitogenic and Anti-insect Potential from the Tubers of Caladium bicolor Vent

  2011cites this paper